Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Proscia

Explore full profile

Developer of pathology cloud technology for use in medicine

Philadelphia, United StatesFounded 2014Biotech & Life Sciences
Valuation $100–250M Last recorded · 2025
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Proscia and the history behind them.

About Proscia

A software company that develops and commercializes a digital pathology platform, Concentriq, to accelerate pathology's transformation toward a data-driven discipline. The platform is designed for image and workflow management in laboratory settings, with a focus on cancer diagnosis and research.

Read full description

The business model is based on providing software as a service (SaaS) to clinical and research laboratories. The company's target clients include anatomic pathology laboratories, contract research organizations (CROs), and pharmaceutical and biotechnology companies. Proscia operates in the digital pathology market, which is a segment of the broader healthcare technology industry.

The company generates revenue through subscriptions to its Concentriq platform and its AI-powered applications. These applications are designed to improve the efficiency and accuracy of pathology workflows, ultimately aiming to enhance patient outcomes in areas like oncology.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Philadelphia, United States
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Proscia.

See all news

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Emerald Development Managers
  • TCP Venture Capital
  • Robin Hood Ventures
  • A-Level Capital

Series A5 investors entered at this stage

Series B and later8 investors entered at this stage

  • Triangle Peak Partners
  • Alpha Intelligence Capital
  • ROBO Global Ventures
  • Hitachi Ventures
  • Highline Capital Management
  • Insight Partners
  • Avenue Capital Group
  • Interwoven Ventures
Employees mapped 127 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States76.2%
🇨🇦 Canada6.9%
🇬🇧 United Kingdom5%
🇮🇪 Ireland4%
🇳🇱 Netherlands3%
Top 5 of 9 shown
Web traffic by country
27K monthly visits
across markets
🇺🇸 United States74.4%
🇨🇦 Canada8.9%
🇮🇳 India4.1%
🇦🇺 Australia3.3%
🇯🇵 Japan2.6%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Proscia on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Proscia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.